18F Radiolabeling via Perfluoroaryl Prosthetic Groups
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for 18F-labeling of biomolecules face challenges such as low concentration of 18F-ions, harsh reaction conditions, and the need for sophisticated purification systems, which can result in loss of activity and require advanced equipment, making it difficult to efficiently produce high-specific-activity radiotracers for PET imaging.
Innovation Solution
The method involves using perfluoroaryl (PFAr) compounds for 18F-labeling, which allows for a mild 19F-to-18F substitution under conditions tolerable by biomolecules, enabling quick radiolabeling while preserving biological activity, and using water-soluble PFAr compounds to facilitate the process, reducing the need for extensive purification and complex radiochemistry.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If direct radiofluorination is used to incorporate 18F ion into biomolecules, then the radiotracer can be produced, but harsh reaction conditions (high temperatures and harsh solvents) are required which are incompatible with biomolecules
Solution Approach 1:
The patent introduces a prosthetic group as an intermediary molecule that first incorporates the 18F radioisotope under controlled conditions, then serves as a bridge to conjugate with the biomolecule. This mediator approach allows the harsh radiofluorination steps to occur on the small-molecule prosthetic group rather than directly on the sensitive biomolecule, resolving the contradiction between production efficiency and biomolecule compatibility.
2Productivity
If conventional 18F-labeling methods are used with polar aprotic solvents and phase transfer catalysts, then 18F incorporation is achieved, but sophisticated purification systems are required leading to loss of activity
Solution Approach 1:
The patent performs the 18F-labeling of the prosthetic group in advance, before conjugation with the biomolecule. This preliminary action allows the radioisotope incorporation to be completed while the biomolecule remains intact and active, simplifying subsequent purification steps and reducing activity loss since the sensitive biomolecule is not exposed to harsh purification conditions.
3Productivity
If high temperature is applied to facilitate 18F-labeling reaction, then the labeling reaction proceeds effectively, but biological activity of the biomolecule is compromised
Solution Approach 1:
The patent divides the overall labeling process into separate stages: first, the prosthetic group is labeled with 18F under high-temperature conditions suitable for effective radioisotope incorporation; second, the labeled prosthetic group is conjugated with the biomolecule under milder conditions. This segmentation allows high-temperature processing to be applied only to the small-molecule prosthetic group, preserving the biological activity of the larger biomolecule.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach enables efficient and rapid production of high-specific-activity 18F-labeled radiotracers with preserved biological activity, suitable for a wide range of biomolecules, and can be adapted for both manual and automated preparation in various facilities, improving the efficiency and simplicity of PET radiotracer production.
Implementation Method 1
reacting the 18F salt with the fluorinated target tracer compound to replace a fluorine atom in the fluorinated target tracer compound with the 18F radioisotope, thereby forming the 18F-labeled radiotracer
Data Source
AI summary
Methods of preparing 18F targeting biomolecules and small molecules with biological activity for therapeutic and/or diagnostic applications using fluorinated aromatic compounds. A fluorinated conjugated target tracer is synthesized and purified with temperature and solvent conditions that are mild for the tracer molecule. The purified fluorinated-conjugated target tracer is then labeled with 18F using 18F salts within a short reaction time, and with temperature and solvent conditions that are mild for the tracer molecule. The method provides a quick and convenient process that maintains the biological activities of the target molecules. The radio-labeled biomolecules may be used as contrast agents for Positron Emission Tomography (PET).